foralumab
Showing 1 - 3 of 3
Crohn's Disease Trial (Foralumab)
Not yet recruiting
- Crohn's Disease
- Foralumab
- (no location specified)
Mar 29, 2022
Covid19, COVID-19 Lower Respiratory Infection, COVID-19 Respiratory Infection Trial (Foralumab, Placebo)
Withdrawn
- Covid19
- +2 more
- Foralumab
- Placebo
- (no location specified)
Feb 14, 2022
NASH - Nonalcoholic Steatohepatitis, NAFLD, T2DM (Type 2 Diabetes) Trial (Foralumab, , Omeprazole 20mg)
Withdrawn
- NASH - Nonalcoholic Steatohepatitis
- +2 more
- Foralumab
- +2 more
- (no location specified)
Sep 10, 2019